Academic Profiles — SynBio Canada

Dr. Marc Aucoin

We aim to characterize viral promoters to control the production of proteins in insect cells with the goal of creating a manufacturing assembly line for complex biologics.

Dr. Grant Brown

Development of yeast chassis for synthetic biology applications.

OntarioBenjamin ScottAugust 9, 2022#yeast, #geneediting, #metabolicengineering, #academic

Dr. Adam Damry

We're a newly established lab looking at how proteins behave at solid interfaces. Most of our understanding of protein science comes from fluid environments. However, solids are another incredibly relevant medium to modern biotech applications, and we don't yet have a strong understanding of how proteins interact with them.

Dr. Alex N. Nguyen Ba

We take advantage of latest synthetic biology approaches to increase the scale or resolution at which we can interrogate the systems biology of the cell.

OntarioBenjamin ScottAugust 7, 2021#mammalian, #yeast, #bacteria, #proteinengineering, #geneediting, #academic

Dr. Miroslava Cuperlovic-Culf

Metabolomics and computational analysis of cells in cultures, bioreactors and biological systems.

OntarioBenjamin ScottAugust 14, 2018#mammalian, #plant, #modeling, #metabolicengineering, #therapeutics

Dr. Trevor Charles

Professor Charles is a microbiologist with expertise in bacterial molecular genetics. His research group studies the mechanisms of gene regulatory circuits that control the interactions of Rhizobiales bacteria such as Sinorhizobium meliloti with their eukaryal hosts.

OntarioBenjamin ScottJuly 19, 2018#bacteria, #entrepreneur, #academic

Dr. Brian Ingalls

Our group uses mathematical and computational tools to construct and analyse kinetic models of biomolecular systems. Our current projects are primarily focused on model-based design of synthetic bacterial gene regulatory systems.

OntarioBenjamin ScottJune 1, 2018#bacteria, #genecircuits, #academic, #modeling

Dr. Mads Kaern

I believe that Synthetic Biology will continue to play a significant role in medical innovation, including engineered virus and engineered immune cells that can cure cancer.

Dr. Sateesh Kagale

We are utilizing Synthetic Biology tools for improving the productivity of agricultural crops. Specifically, we apply precise gene editing tools to improve tolerance to pests, diseases and abiotic stress of economically important agricultural crops, such as wheat, canola and pulse.

OntarioBenjamin ScottMay 16, 2018#yeast, #bacteria, #geneediting, #greentech, #academic

Dr. Bogumil Karas

Research in the Karas lab is focused on developing innovative genetic tools to enable the engineering of microbes to produce medicines, DNA storage technologies, food and next-generation fuels.

BioZone

BioZone aims to use Bioengineering to create a sustainable world by making industrial processes more sustainable, remediating humanity's environmental impact, and improving health outcome.

Dr. Radhakrishnan Mahadevan

Our group primarily works on engineering metabolism in bacteria and yeast to produce chemicals and therapeutic molecules. Through the use of computational strategies on genome scale metabolic models of these organisms, we identify genetic intervention strategies to enhance target molecule production.

Dr. Scott McComb

Chimeric antigen receptor T cells (CAR-T) are an exciting new avenue to redirect immune cells to target and kill cancer. While breakthroughs in CAR-T therapy have led to life-saving treatments for patients with previously incurable leukemia, such therapies have been less successful against solid tumours.

OntarioBenjamin ScottApril 18, 2018#mammalian, #geneediting, #therapeutics, #academic

Dr. David McMillen

We work on (mainly) microbial synthetic biology, investigating ways to create novel solutions to real-world problems with engineered microbes.

OntarioBenjamin ScottApril 10, 2018#yeast, #bacteria, #modeling, #genecircuits, #biosensor, #entrepreneur

Dr. Moira McQueen

As a bioethicist, I am interested in the science and development of synthetic biology and in ethical questions that arise from its use, as well as in its impact on health care, the workforce and the environment.

OntarioBenjamin ScottApril 6, 2018#geneediting, #therapeutics, #academic, #policy

Dr. Gabriel Moreno-Hagelsieb

My work is about gene-product interactions, which can be represented as networks and modules.

OntarioBenjamin ScottApril 3, 2018#bacteria, #modeling, #academic

Dr. Jimin Guo

We develop new methods in the domains of Genomics and Synthetic Biology, using microfluidics and computational biology.

OntarioBenjamin ScottMarch 21, 2018#mammalian, #yeast, #bacteria, #cellfree, #genecircuits, #biosensor

Dr. Rebecca Shapiro

My research group at the University of Guelph is developing new CRISPR-based platforms for functional genomic analysis in fungal pathogens.

OntarioBenjamin ScottFebruary 16, 2018#yeast, #geneediting, #therapeutics, #academic

Dr. Valerie Ward

We aim to engineer microalgae to produce proteins for medical and industrial uses as well as engineer metabolic pathways in microbial platforms for the production of isoprenoids.

OntarioBenjamin ScottFebruary 5, 2018#bacteria, #cellfree, #metabolicengineering, #therapeutics, #greentech, #academic

Dr. Andrew Woolley

Optogenetic control, photo-controlled proteins

OntarioBenjamin ScottFebruary 3, 2018#proteinengineering